| Stephen N Zonca, MD | |
|
1316 Mercy Dr, Muskegon, MI 49444-1835 | |
| (231) 739-9461 | |
| (231) 733-8131 |
| Full Name | Stephen N Zonca |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 29 Years |
| Location | 1316 Mercy Dr, Muskegon, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255394482 | NPI | - | NPPES |
| 4390540 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | O65662 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health Vns | Muskegon, MI | Home health agency |
| Mercy Health Hackley Campus | Muskegon, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Muskegon Surgical Associates Pc | 0941262877 | 26 |
News Archive
Choking is a leading cause of injury and death among children, especially those younger than 4 years of age. The majority of choking-related incidents among children are associated with food, coins and toys. A new policy statement from the American Academy of Pediatrics (AAP), led by a doctor at Nationwide Children's Hospital and published in the February 22 online issue of Pediatrics, takes a closer look at preventing choking among children.
CTI BioPharma Corp. today announced that it has acquired worldwide rights to tosedostat through concurrent transactions with Vernalis R&D Limited, the originator of tosedostat, and Chroma Therapeutics Ltd., through which CTI previously held a sublicense with respect to tosedostat in North, Central and South America.
AMSURG Corp. and Sheridan Healthcare, a portfolio company of Hellman & Friedman, LLC, today announced that their respective Boards of Directors have unanimously approved a definitive agreement under which AMSURG will acquire Sheridan Healthcare in a cash and stock transaction valued at approximately $2.35 billion.
National Institutes of Health researchers have uncovered a key factor in understanding the elevated cancer risk associated with gene therapy. They conducted research on mice with a rare disease similar to one in humans, hoping their findings may eventually help improve gene therapy for humans. Researchers at the National Human Genome Research Institute, part of NIH, published their research in the Jan. 20, 2015, online issue of the Journal of Clinical Investigation.
› Verified 2 days ago
| Entity Name | Muskegon Surgical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225101660 PECOS PAC ID: 0941262877 Enrollment ID: O20041102000715 |
News Archive
Choking is a leading cause of injury and death among children, especially those younger than 4 years of age. The majority of choking-related incidents among children are associated with food, coins and toys. A new policy statement from the American Academy of Pediatrics (AAP), led by a doctor at Nationwide Children's Hospital and published in the February 22 online issue of Pediatrics, takes a closer look at preventing choking among children.
CTI BioPharma Corp. today announced that it has acquired worldwide rights to tosedostat through concurrent transactions with Vernalis R&D Limited, the originator of tosedostat, and Chroma Therapeutics Ltd., through which CTI previously held a sublicense with respect to tosedostat in North, Central and South America.
AMSURG Corp. and Sheridan Healthcare, a portfolio company of Hellman & Friedman, LLC, today announced that their respective Boards of Directors have unanimously approved a definitive agreement under which AMSURG will acquire Sheridan Healthcare in a cash and stock transaction valued at approximately $2.35 billion.
National Institutes of Health researchers have uncovered a key factor in understanding the elevated cancer risk associated with gene therapy. They conducted research on mice with a rare disease similar to one in humans, hoping their findings may eventually help improve gene therapy for humans. Researchers at the National Human Genome Research Institute, part of NIH, published their research in the Jan. 20, 2015, online issue of the Journal of Clinical Investigation.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen N Zonca, MD 1316 Mercy Dr, Muskegon, MI 49444-1835 Ph: (231) 739-9461 | Stephen N Zonca, MD 1316 Mercy Dr, Muskegon, MI 49444-1835 Ph: (231) 739-9461 |
News Archive
Choking is a leading cause of injury and death among children, especially those younger than 4 years of age. The majority of choking-related incidents among children are associated with food, coins and toys. A new policy statement from the American Academy of Pediatrics (AAP), led by a doctor at Nationwide Children's Hospital and published in the February 22 online issue of Pediatrics, takes a closer look at preventing choking among children.
CTI BioPharma Corp. today announced that it has acquired worldwide rights to tosedostat through concurrent transactions with Vernalis R&D Limited, the originator of tosedostat, and Chroma Therapeutics Ltd., through which CTI previously held a sublicense with respect to tosedostat in North, Central and South America.
AMSURG Corp. and Sheridan Healthcare, a portfolio company of Hellman & Friedman, LLC, today announced that their respective Boards of Directors have unanimously approved a definitive agreement under which AMSURG will acquire Sheridan Healthcare in a cash and stock transaction valued at approximately $2.35 billion.
National Institutes of Health researchers have uncovered a key factor in understanding the elevated cancer risk associated with gene therapy. They conducted research on mice with a rare disease similar to one in humans, hoping their findings may eventually help improve gene therapy for humans. Researchers at the National Human Genome Research Institute, part of NIH, published their research in the Jan. 20, 2015, online issue of the Journal of Clinical Investigation.
› Verified 2 days ago
Dr. Joel Brougher Anderson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1316 Mercy Dr, Muskegon, MI 49444 Phone: 231-739-9461 Fax: 231-733-8131 | |
Dr. Arthur Hongbin Kim, MD Surgery Medicare: Medicare Enrolled Practice Location: 1500 E Sherman Blvd, Muskegon, MI 49444 Phone: 231-672-2000 | |
Jennifer Lynn Bradley, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1316 Mercy Dr, Muskegon, MI 49444 Phone: 231-739-9461 | |
Lawrence I Mallon, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1316 Mercy Dr, Muskegon, MI 49444 Phone: 231-739-9461 Fax: 231-733-8131 | |
Dr. Ryan M Bylsma, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1560 E Sherman Blvd Ste 309, Muskegon, MI 49444 Phone: 231-672-8643 Fax: 231-672-8651 | |
Srdjan Andrei Ostric, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1675 Patriot Dr, Muskegon, MI 49444 Phone: 231-739-9461 Fax: 231-739-1984 |